AirCurve 10 ST-A

AirCurve 10 ST-A Description

The ResMed AirCurve 10 ST-A is a highly effective ventilator that provides effective non-invasive ventilation for patients with respiratory insufficiency such as neuromuscular disease, restrictive lung disorders, severe COPD and hypoventilation syndromes. It also allows you to proactively monitor and follow up with respiratory insufficiency patients.

The AirCurve 10 ST-A includes both fixed and adjustable alarms for added safety and built-in cellular connectivity to AirView™ for remote monitoring and optimal in-patient care. It features iVAPS (intelligent Volume-Assured Pressure Support).

Features:

Patient-ventilator synchronization – Vsync™ and TiControl™ features provide patient-ventilator synchrony, ensuring timely intervention during challenging conditions or leak
Optimal climate control – HumidAir™ humidifier and the ClimateLineAir™ heated air tube provide optimal climate control by delivering constant, comfortable temperature and humidity levels
Adjustable trigger and cycle that can be used to optimize synchrony between the device and your own respiratory efforts
QuickNav allows for low-touch therapy adjustment allows you to toggle between the Monitoring and Settings screens to change and check settings quickly and easily
Ramp Down allows you to gradually reduce pressure support for a more comfortable transition to spontaneous breathing

Included:

Device
Humidifier
Water tank
Air tubing
Power supply unit
Travel bag
SD card (already inserted)
Manuals

Brand

ResMed

ResMed is a pioneer in sleep apnea treatment options. Established in 1989, ResMed has grown into a global leader in developing, manufacturing and distributing innovative medical devices such as CPAP machines and masks, as well as CPAP software solutions to better diagnose, treat, and manage sleep apnea, COPD and other respiratory diseases.In 2017, ResMed became an S&P 500 company with its annual revenues exceeding $2 billion. To date, ResMed operates in more than 120 countries and employs over 6,000 worldwide. Their mission is to change 20 million lives by 2020.